Unmatched Expertise and Compassionate Care for Myeloma
Myeloma is a bone marrow
cancer that starts in the plasma cells. Plasma cells are white blood cells that
are part of the immune system. When plasma cells become malignant, they affect
healthy blood cell production, which weakens the immune system. If left
untreated, the cancerous cells can lead to kidney damage and bone destruction.
More than 90 percent of
patients diagnosed with myeloma have multiple myeloma, which means that the
cancerous cells, known as myeloma cells once they are malignant, have developed
in more than one location in the bone marrow.
While myeloma is not curable,
it is treatable, especially at a top cancer center like UT Southwestern that
has the newest therapies.
For patients with myeloma,
- Myeloma expertise
that is unmatched in Dallas-Ft. Worth
- Access to
cutting-edge treatments and clinical trial research for every stage of myeloma
- Bone marrow transplant
and nontransplant treatment modalities
for one physician to handle all of a patient’s care, from diagnosis to
transplant and beyond
32-bed hospital unit built specifically for immunocompromised patients
- A broad range
of support services that provide
care beyond treatment, for both our patients and their families
As a new member of the
elite Multiple Myeloma Research Foundation, we have access to even more new
treatments earlier than other facilities, and we are supporting the continued
advancement of myeloma therapies. At any time, we have eight to 10 myeloma clinical
trials available to our patients.